English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/113133
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Selective, nontoxic CB2 cannabinoid o-quinone with in vivo activity against triple-negative breast cancer

AutorMorales, Paula ; Blasco-Benito, S.; Andradas, C.; Gómez-Cañas, María; Flores, Juana María; Goya, Pilar ; Fernández-Ruiz, Javier; Sánchez, Cristina; Jagerovic, Nadine
Fecha de publicación2015
EditorAmerican Chemical Society
CitaciónJournal of Medicinal Chemistry 58: 2256- 2264 (2015)
ResumenTriple-negative breast cancer (TNBC) represents a subtype of breast cancer characterized by high aggressiveness. There is no current targeted therapy for these patients whose prognosis, as a group, is very poor. Here, we report the synthesis and evaluation of a potent antitumor agent in vivo for this type of breast cancer designed as a combination of quinone/cannabinoid pharmacophores. This new compound (10) has been selected from a series of chromenopyrazolediones with full selectivity for the nonpsychotropic CB2 cannabinoid receptor and with efficacy in inducing death of human TNBC cell lines. The dual concept quinone/cannabinoid was supported by the fact that compound 10 exerts antitumor effect by inducing cell apoptosis through activation of CB2 receptors and through oxidative stress. Notably, it did not show either cytotoxicity on noncancerous human mammary epithelial cells nor toxic effects in vivo, suggesting that it may be a new therapeutic tool for the management of TNBC.
URIhttp://hdl.handle.net/10261/113133
DOI10.1021/acs.jmedchem.5b00078
Identificadoresdoi: 10.1021/acs.jmedchem.5b00078
issn: 0022-2623
e-issn: 1520-4804
Aparece en las colecciones: (IQM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.